AU2002216946A1 - Modified pna molecules - Google Patents

Modified pna molecules

Info

Publication number
AU2002216946A1
AU2002216946A1 AU2002216946A AU2002216946A AU2002216946A1 AU 2002216946 A1 AU2002216946 A1 AU 2002216946A1 AU 2002216946 A AU2002216946 A AU 2002216946A AU 2002216946 A AU2002216946 A AU 2002216946A AU 2002216946 A1 AU2002216946 A1 AU 2002216946A1
Authority
AU
Australia
Prior art keywords
pna molecules
modified pna
modified
molecules
pna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216946A
Inventor
Muthiah Manoharan
Peter Eigil Nielsen
Ask Puschl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pantheco AS
Original Assignee
Pantheco AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantheco AS filed Critical Pantheco AS
Publication of AU2002216946A1 publication Critical patent/AU2002216946A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
AU2002216946A 2001-01-05 2002-01-03 Modified pna molecules Abandoned AU2002216946A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200100021 2001-01-05
DKPA200100021 2001-01-05
PCT/DK2002/000005 WO2002053574A2 (en) 2001-01-05 2002-01-03 Modified pna molecules

Publications (1)

Publication Number Publication Date
AU2002216946A1 true AU2002216946A1 (en) 2002-07-16

Family

ID=8159969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216946A Abandoned AU2002216946A1 (en) 2001-01-05 2002-01-03 Modified pna molecules

Country Status (2)

Country Link
AU (1) AU2002216946A1 (en)
WO (1) WO2002053574A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10370415B2 (en) 2013-04-11 2019-08-06 Carnegie Mellon University Divalent nucleobase compounds and uses therefor
US10221216B2 (en) 2013-04-11 2019-03-05 Carnegie Mellon University Template-directed γPNA synthesis process and γPNA targeting compounds
CN109923105A (en) 2016-09-26 2019-06-21 卡耐基梅隆大学 Divalent nucleobase compound and application thereof
US20230242587A1 (en) * 2020-04-17 2023-08-03 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Thyclotides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621367D0 (en) * 1996-10-14 1996-12-04 Isis Innovation Chiral peptide nucleic acids
EP0975370B9 (en) * 1997-05-21 2004-11-03 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for enhancing transport across biological membranes
AU741546B2 (en) * 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
CA2388991A1 (en) * 1998-11-11 2001-04-19 Peter E. Nielsen Conjugates between a peptides and a nucleic acid analog, such as a pna, lna or a morpholino
IL143983A0 (en) * 1999-01-08 2002-04-21 Amaxa Gmbh Use of cellular transport systems for the transfer of nucleic acids through the nuclear envelope
WO2001076636A2 (en) * 2000-04-06 2001-10-18 Pantheco A/S Pharmaceutical composition of modified pna molecules

Also Published As

Publication number Publication date
WO2002053574A3 (en) 2002-10-24
WO2002053574A2 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AUPQ339899A0 (en) Novel molecules
AU2002245332A1 (en) Anergy-regulated molecules
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2002368044A1 (en) Co-stimulatory molecules
AU2002337312A1 (en) Molecules
AU2002258388A1 (en) Narc8 programmed cell-death-associated molecules and uses thereof
AU2002359320A1 (en) Novel anit-infectives
AU2002335439A1 (en) Clip
AUPR535101A0 (en) Novel therapeutic molecules
EP1572168A3 (en) Anti-infarction molecules
AU2002216946A1 (en) Modified pna molecules
AU2002365927A1 (en) Vesicle-associated proteins
AU2002334632A1 (en) Lipid-associated molecules
AU2002309917A1 (en) Lipid-associated molecules
AU2002250040A1 (en) Lipid-associated molecules
AU2002236594A1 (en) Lipid-associated molecules
AUPR166900A0 (en) Novel molecules
AUPQ632700A0 (en) Novel molecules
AU2002328863A1 (en) Oncosuppressive gene
AUPR899701A0 (en) Improved sign
AU2002219364A1 (en) Adhesion molecules
AU2002360832A1 (en) Aggrecanase molecules
AU2002319703A1 (en) Aggrecanase molecules
AUPR547301A0 (en) Sign
AUPR354901A0 (en) Sign

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase